Michael  Chi net worth and biography

Michael Chi Biography and Net Worth

Chief Commercial Officer of Hims & Hers Health
Mike Chi is our Chief Commercial Officer. He joined Hims & Hers in April 2021. Mike has over 20 years of experience in consumer focused businesses and brings deep expertise in brand positioning, growth marketing, product management and merchandising strategy. Previously, he was the Chief Marketing Officer at Zola, a suite of online wedding planning tools. He was also the Vice President of Marketing and digital experience at INTERMIX and held various senior positions across marketing and general management at Gilt Groupe. He holds an MBA from Columbia Business School and a B.A. from Brown University.

What is Michael Chi's net worth?

The estimated net worth of Michael Chi is at least $7.17 million as of February 24th, 2025. Mr. Chi owns 193,601 shares of Hims & Hers Health stock worth more than $7,174,853 as of March 25th. This net worth evaluation does not reflect any other assets that Mr. Chi may own. Learn More about Michael Chi's net worth.

How do I contact Michael Chi?

The corporate mailing address for Mr. Chi and other Hims & Hers Health executives is 2269 CHESTNUT STREET SUITE 523, SAN FRANCISCO CA, 94123. Hims & Hers Health can also be reached via phone at 415-851-0195 and via email at hims-ir@westwicke.com. Learn More on Michael Chi's contact information.

Has Michael Chi been buying or selling shares of Hims & Hers Health?

During the last ninety days, Michael Chi has sold $1,858,284.07 in Hims & Hers Health stock. Most recently, Michael Chi sold 17,303 shares of the business's stock in a transaction on Monday, February 24th. The shares were sold at an average price of $48.14, for a transaction totalling $832,966.42. Following the completion of the sale, the insider now directly owns 193,601 shares of the company's stock, valued at $9,319,952.14. Learn More on Michael Chi's trading history.

Who are Hims & Hers Health's active insiders?

Hims & Hers Health's insider roster includes Jack Abraham (Major Shareholder), Melissa Baird (COO), Soleil Boughton (Insider), Patrick Carroll (Insider), Michael Chi (Chief Commercial Officer), Andrew Dudum (Co-Founder, Chairman & CEO), Spencer Lee (CFO), Anja Manuel (Director), Oluyemi Okupe (CFO), Christopher Payne (Director), and David Wells (Director). Learn More on Hims & Hers Health's active insiders.

Are insiders buying or selling shares of Hims & Hers Health?

In the last year, Hims & Hers Health insiders bought shares 3 times. They purchased a total of 115,000 shares worth more than $2,084,023.00. In the last year, insiders at the sold shares 87 times. They sold a total of 3,821,427 shares worth more than $93,197,218.35. The most recent insider tranaction occured on March, 18th when insider Patrick Harrison Carroll sold 23,287 shares worth more than $798,976.97. Insiders at Hims & Hers Health own 17.7% of the company. Learn More about insider trades at Hims & Hers Health.

Information on this page was last updated on 3/18/2025.

Michael Chi Insider Trading History at Hims & Hers Health

See Full Table

Michael Chi Buying and Selling Activity at Hims & Hers Health

This chart shows Michael Chi's buying and selling at Hims & Hers Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$1.86MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1M$0$1MTotal Insider BuyingTotal Insider Selling

Hims & Hers Health Company Overview

Hims & Hers Health logo
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Read More

Today's Range

Now: $37.06
Low: $35.77
High: $38.69

50 Day Range

MA: $39.44
Low: $26.19
High: $68.87

2 Week Range

Now: $37.06
Low: $11.20
High: $72.98

Volume

17,491,541 shs

Average Volume

13,881,126 shs

Market Capitalization

$8.23 billion

P/E Ratio

84.23

Dividend Yield

N/A

Beta

1.37